AI Article Synopsis
- * The main treatment for severe alcohol-associated hepatitis (AH) is corticosteroids, but not all patients respond effectively to this treatment.
- * The article discusses key nutritional concepts for ALD and new insights into predicting how patients will respond to corticosteroids and their overall prognosis.
Article Abstract
Patients with alcohol-associated liver disease (ALD) consume large amounts of empty calories and are at risk for malnutrition. Malnutrition can present with micro- or macro-nutrient deficiencies. The standard-of-care drug treatment for severe alcohol-associated hepatitis (AH) is corticosteroids. While still in the standard treatment there are limitations in efficacy and certain patients do not respond to treatment (Lille score ≥.45). This article will focus on important concepts related to nutrition and ALD and on recent findings on predicting corticosteroid response and prognosis for AH patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11529778 | PMC |
| http://dx.doi.org/10.1016/j.cld.2024.06.018 | DOI Listing |
Publication Analysis
Top Keywords
alcohol-associated liver
8
liver disease
8
current pharmacotherapy
4
pharmacotherapy nutrition
4
nutrition therapy
4
therapy alcohol-associated
4
disease patients
4
patients alcohol-associated
4
disease ald
4
ald consume
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!